Candel Therapeutics, Inc. (CADL)

Candel Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	35.68	70.32	83.07	35.05	5.18
Short-Term Investments	0	0	0	0	39.88
Cash & Cash Equivalents	35.68	70.32	83.07	35.05	45.06
Cash Growth	-49.26%	-15.34%	136.97%	-22.20%	-
Other Current Assets	1.12	1.62	1.88	0.09	0.15
Total Current Assets	36.8	71.95	84.95	35.15	45.21
Property, Plant & Equipment	4.02	5.48	3.84	2.79	0.43
Other Long-Term Assets	0.38	0.27	0.42	0.35	0.27
Total Long-Term Assets	4.4	5.75	4.26	3.14	0.69
Total Assets	41.2	77.69	89.21	38.28	45.9
Accounts Payable	0.42	0.38	1.59	0.92	0.22
Deferred Revenue	0	0.14	0	0.13	0.25
Current Debt	9.41	0.46	0	0.46	0
Other Current Liabilities	4.36	4.63	3.77	3.2	0.94
Total Current Liabilities	14.18	5.62	5.36	4.71	1.41
Long-Term Debt	13.36	22.34	0.56	0.48	0.42
Other Long-Term Liabilities	0.92	2.03	19.15	7.59	3.05
Total Long-Term Liabilities	14.27	24.36	19.71	8.07	3.47
Total Liabilities	28.46	29.98	25.07	12.78	4.88
Total Debt	22.76	22.8	0.56	0.95	0.42
Debt Growth	-0.17%	3971.43%	-40.80%	125.24%	-
Retained Earnings	-137.03	-99.09	-80.3	-44.17	-26.49
Comprehensive Income	0	0	0	0	-0.02
Shareholders' Equity	12.75	47.71	64.14	-23.56	-8.04
Net Cash / Debt	12.92	47.52	82.51	34.11	44.64
Net Cash / Debt Growth	-72.82%	-42.40%	141.90%	-23.59%	-
Net Cash Per Share	0.45	1.65	4.37	2.94	3.87
Working Capital	22.61	66.33	79.58	30.43	43.8
Book Value Per Share	0.44	1.66	3.40	-2.03	-0.70

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).